17.01.2025 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025 download […]

13.12.2024 To the attention of interested persons Alofisel withdrawn from the EU market download document …

09.12.2024 To the attention of interested persons ETF statement on the loss of activity of anti-spike protein monoclonal antibodies due […]

29.11.2024 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2024 download […]

15.11.2024 To the attention of interested persons Updated advice to minimise risks of interaction between weight loss medicine Mysimba and […]

14.11.2024 To the attention of interested persons Leqembi recommended for treatment of early Alzheimer’s disease download document …

18.10.2024 To the attention of interested persons Translarna: EMA re-confirms non-renewal of authorisation of Duchenne muscular dystrophy medicine download document […]

04.10.2024 To the attention of interested persons EMA starts safety review of medicines containing finasteride and dutasteride download document …

20.09.2024 To the attention of interested persons EMA recommends measures to minimise serious outcomes of known side effect with painkiller […]